OTC Markets OTCPK USD

WuXi Biologics (Cayman) Inc. (WXIBF)

6.45 +0.55 (+9.32%)

At close: October 30 at 5:00:00 PM EDT

 All 
 News 
 Earnings Calls 
 Press Releases 
 SEC Filings 

Missed WuXi Biologics' Run? Here's The Bet Holders Made

Simply Wall St. 7h ago

2269.HK
Fresenius and WuXi team up in 37-strong biosimilar development deal

Pharmaceutical Technology 1d ago

FRE.DE

2269.HK
Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline

PR Newswire 1d ago

FRE.DE

2269.HK

FRE.F
WuXi Biologics Receives Top-Honor Jade Award at The Asset Corporate Sustainability Leadership Awards 2026

PR Newswire 13d ago

2269.HK
Can WuXi Biologics (Cayman) (SEHK:2269) Stay Reasonable As Capacity Expands?

Simply Wall St. 14d ago

2269.HK
WuXi Biologics Continues to Be Included in Multiple Hang Seng Sustainability Indexes, Demonstrating ESG Excellence

PR Newswire 20d ago

2269.HK

2269
Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption

GlobeNewswire 1mo ago

2269.HK

BIO

SYNGENE.NS
WuXi Biologics Passes Another FDA GMP Inspection, Reinforcing Its Quality Track Record and Commercial Supply Reliability

PR Newswire 1mo ago

2269.HK

2269
WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership

PR Newswire 1mo ago

2269.HK

2269
Big Pharma Is Pouring Billions Into China’s Biotechs

Barrons.com 1mo ago

AZN

ZLAB

1093.HK
WuXi Biologics Reports Strong Profitable Growth in H1 2026

PR Newswire 2mo ago

2269.HK

2268.HK
WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO

PR Newswire 2mo ago

2269.HK

MRK

LLY

Performance Overview

Return	WXIBF	HANG SENG INDEX (^HSI)
YTD	+52.84%	-8.21%
1-Year	+40.22%	-10.06%
3-Year	+0.78%	+33.19%

U.S. markets closed

WuXi Biologics (Cayman) Inc. (WXIBF)

Missed WuXi Biologics' Run? Here's The Bet Holders Made

Fresenius and WuXi team up in 37-strong biosimilar development deal

Fresenius and WuXi Biologics enter exclusive development agreement to expand biosimilars pipeline

WuXi Biologics Receives Top-Honor Jade Award at The Asset Corporate Sustainability Leadership Awards 2026

Can WuXi Biologics (Cayman) (SEHK:2269) Stay Reasonable As Capacity Expands?

WuXi Biologics Continues to Be Included in Multiple Hang Seng Sustainability Indexes, Demonstrating ESG Excellence

Recombinant Proteins Manufacturing Services Market Report Released; 19.7% CAGR as revenue nearly triples from $5.2B to $15.3B by 2030; benchmark WuXi Biologics, GenScript, Bio-Rad, ACROBiosystems and Syngene amid tariff disruption

WuXi Biologics Passes Another FDA GMP Inspection, Reinforcing Its Quality Track Record and Commercial Supply Reliability

WuXi Biologics Named to Forbes China ESG 50 List 2026 for Green CRDMO and Digital ESG Leadership

Big Pharma Is Pouring Billions Into China’s Biotechs

WuXi Biologics Reports Strong Profitable Growth in H1 2026

WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry's Transformation Through Green CRDMO